FDA Inspection 1009077 — Rosario B. Retino, MD
The FDA completed an inspection of Rosario B. Retino, MD on April 6, 2017 in Ontario, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 6, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Ontario, CA (United States)
Additional Details
Clinical Investigator (CI)